Literature DB >> 20548812

Update on hypertrophic cardiomyopathy.

Ali J Marian1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20548812      PMCID： PMC2879188     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  9 in total

1.  Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy.

Authors:  A J Marian
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

Review 2.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

3.  Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.

Authors:  R Patel; S F Nagueh; N Tsybouleva; M Abdellatif; S Lutucuta; H A Kopelen; M A Quinones; W A Zoghbi; M L Entman; R Roberts; A J Marian
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

4.  Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy.

Authors:  Vinitha Senthil; Suet N Chen; Natalie Tsybouleva; Tripti Halder; Sherif F Nagueh; James T Willerson; Robert Roberts; A J Marian
Journal:  Circ Res       Date:  2005-07-14       Impact factor: 17.367

Review 5.  Genetic determinants of cardiac hypertrophy.

Authors:  Ali J Marian
Journal:  Curr Opin Cardiol       Date:  2008-05       Impact factor: 2.161

6.  Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation.

Authors:  Ali J Marian; Vinitha Senthil; Suet N Chen; Raffaella Lombardi
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

7.  Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.

Authors:  Barry J Maron; Joseph J Doerer; Tammy S Haas; David M Tierney; Frederick O Mueller
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

8.  Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.

Authors:  Natalia Tsybouleva; Lianfeng Zhang; Suetnee Chen; Rajnikant Patel; Silvia Lutucuta; Shintaro Nemoto; Gilberto DeFreitas; Mark Entman; Blase A Carabello; Robert Roberts; A J Marian
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

9.  Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms.

Authors:  Raffaella Lombardi; Gabriela Rodriguez; Suet Nee Chen; Crystal M Ripplinger; Wenwen Li; Junjie Chen; James T Willerson; Sandro Betocchi; Samuel A Wickline; Igor R Efimov; Ali J Marian
Journal:  Circulation       Date:  2009-03-02       Impact factor: 29.690
  9 in total
  2 in total

1.  Defining genotype-phenotype relationships in patients with hypertrophic cardiomyopathy using cardiovascular magnetic resonance imaging.

Authors:  Robert J H Miller; Shahriar Heidary; Aleksandra Pavlovic; Audrey Schlachter; Rajesh Dash; Dominik Fleischmann; Euan A Ashley; Matthew T Wheeler; Phillip C Yang
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

2.  An Investigation of Fibulin-2 in Hypertrophic Cardiomyopathy.

Authors:  Ayman M Ibrahim; Mohamed Roshdy; Sara Elshorbagy; Mohammed Hosny; Sarah Halawa; Dina Yehia; Hasnaa A Elfawy; Ahmed Eldessouki; Faisal Mohamed; Amany Ellithy; Mohamed Abdelfattah; Amr Elsawy; Mohamed Elkhatib; Mona Allouba; Ahmed Elguindy; Yasmine Aguib; Magdi Yacoub
Journal:  Int J Mol Sci       Date:  2020-09-29       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.